EMEA guidelines - New guidance on drug trials

被引：0

|

作者：

Houlton, Sarah

机构：

来源：

CHEMISTRY & INDUSTRY | 2007年 / 16期

关键词：

D O I：

暂无

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

引用

下载

收藏

页码：12 / 12

页数：1

相关论文

共 50 条

[1] The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials
S Marchetti
J H M Schellens
British Journal of Cancer, 2007, 97 : 577 - 581
[2] The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials
Marchetti, S.
Schellens, J. H. M.
BRITISH JOURNAL OF CANCER, 2007, 97 (05) : 577 - 581
[3] EMEA guidelines for trials in osteoporosis: design implications
Boers, M
NETHERLANDS JOURNAL OF MEDICINE, 2002, 60 (08): : 310 - 314
[4] First-in-human clinical trials: Comparison of EMEA and FDA guidelines
Hernandez-Lopez, Candido
MEDICINA CLINICA, 2009, 132 (01): : 30 - 34
[5] The new EMEA note for guidance on the clinical development of anticancer agents
Schellens, JHM
ANNALS OF ONCOLOGY, 2006, 17 : 21 - 22
[6] EMEA guidelines on biosimilars and their clinical implications
Rossert, Jerome
KIDNEY & BLOOD PRESSURE RESEARCH, 2007, 30 : 13 - 17
[7] New ethics guidance for trials
不详
SCIENCE, 2014, 346 (6209) : 528 - 528
[8] New guidance on clinical trials
British Dental Journal, 2008, 204 (2) : 57 - 57
[9] EMEA provide guidance on gadolinium contrast agents
Reactions Weekly, 2009, 1280 (1) : 1 - 1
[10] GUIDELINES FOR ANTIEPILEPTIC DRUG TRIALS IN CHILDREN
GRAM, L
DULAC, O
FREY, HH
GONZALESASTIAZARAN, A
LEPPIK, I
LOISEAU, P
PERRET, A
EPILEPSIA, 1994, 35 (01) : 94 - 100

← 1 2 3 4 5 →